CRISPR/Cas9 is making gene-editing cheaper and easier than ever before, but the creators are embroiled in a fierce dispute over who holds the patents to CRISPR technology. In this episode, after hearing attorneys duke it out, Ryan Cross explains how the kerfuffle developed, and what the possible outcomes of the impending decision mean.
The Legal Battle Over CRISPR
The lowdown on the CRISPR gene-editing patent dispute at the U.S. Patent & Trademark Office.
Jan 10, 2017
Latest in Chemical Processing